ArticleACS pharmacology & translational science2026

Chemically Defined Non-human Glycans Comprising Galactose-α1-3-Galactose (α-Gal) Epitopes Glycoengineered into the Fragment Antigen-Binding (Fab) Domain of Cetuximab Differentially Affect Human Anti-α-Gal Immunoglobulin E (IgE) Binding.

Grayson Hatfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.